The company has informed the government that it is currently in the process of submitting documents, particularly regarding validation of one of its manufacturing facilities. It is also submitting the documents for completion of Phase 3 trials for Covaxin to the WHO, which will be completed by the third week of June.
Posted from: this blog via Microsoft Power Automate.
